NCH2.DENCH2.DEXETRA
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank20
3Y CAGR-41.6%
5Y CAGR-33.3%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
-41.6%/yr
Annual compound
5Y CAGR
-33.3%/yr
Recent deceleration
Percentile
P20
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthCompressed
PeriodValueYoY Change
20251.54+12.7%
20241.37-54.6%
20233.02-61.1%
20227.75-16.6%
20219.30-20.4%
202011.69-